Biotechnology
GenScript Signs a Strategic Partnership with the Theragen Etex and MedPACTO for Therapeutic Antibody Drug development
SINGAPORE, March 25, 2021 /PRNewswire/ -- A global leading biotech company GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) announced that the Company has entered into a strategic partnership with the Theragen Etex, a South Korea-based comprehensive pharmaceutical and biotechnology...
2021-03-25 16:35
4830
Ascentage Pharma's First Third-Generation BCR-ABL Inhibitor in China Olverembatinib (HQP1351) Recommended for Breakthrough Therapy Designation
SUZHOU, China and ROCKVILLE, Md., March 24, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Ev...
2021-03-24 19:07
2632
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
* Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA acrossLatin America, Asia, Europe and Africa * Interim analysis of the primary endpoint expected in the middle of 2021 CHENGDU, China and EMERYVILLE, Calif., March 24, 2021 /PRNewswire/ -- Clover Biopharm...
2021-03-24 14:18
3709
CStone Announces New Drug Approval of GAVRETO(R) (pralsetinib) as First Selective RET Inhibitor in China, Providing a New Therapy for a Subset of Non-Small Cell Lung Cancer Patients
* GAVRETO has been approved for the treatment of adults with locally advanced or metastatic RET fusion-positive non-small cell lung cancer after platinum-based chemotherapy * GAVRETO is the first approved selective RET inhibitor in China and first approved precision therapy for CStone SUZHOU,...
2021-03-24 10:46
5820
Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data
RARITAN, N.J., March 23, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received authorization from the U.S. Food and Drug Administration to update key claims for the VITROS® SARS-CoV-2 Antige...
2021-03-23 20:00
3429
Pharmactive Earns Acclaim from Frost & Sullivan for Helping People Improve their Cognitive Functions with its Saffron-based Ingredient, Affron®
The company's proven ability to reduce symptoms of occasional depression with Affron®, and its strong focus on quality control, have helped it deliver a truly outstanding product LONDON, March 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American market for industrial enter...
2021-03-23 20:00
1616
Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)
PARIS, March 23, 2021 /PRNewswire/ -- Unither Pharmaceuticals, the
Blow-Fill-Seal (BFS) worldwide leader, provides diagnostic companies with
capacity solutions and innovative technologies for their testing kits (Covid,
Flu, etc.).
2021-03-23 15:04
2881
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary
* Marks vaccine's first approval by an European Union member state, following Mexico, Pakistan and China * Continues to boost production capacity to meet increasing demand * Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions * 95.47% effectiv...
2021-03-23 00:43
4386
Xylonix Reveals New Drug Compound for Combating Cancer and Abnormal Macrophages
SINGAPORE, March 22, 2021 /PRNewswire/ -- Xylonix, a Singapore-based biotech company, has developed a new immunity drug (010DS-Zn) that demonstrates potential for treating a variety of solid cancers and COVID-19's post-recovery complications, which include heart damage, diabetes and multi-system ...
2021-03-22 21:00
1997
Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company
- Combined company will generate well over $100 million of ARR and signals a significant transformation in the future of software and data management in research labs. - Enabling over one million scientists to improve research and lab efficiency. - Facilitating rapid data access and exchange bet...
2021-03-22 19:03
3995
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland
TEL AVIV, Israel and RALEIGH, N.C., March 22, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-03-22 19:00
4270
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2020
SHANGHAI, March 22, 2021 /PRNewswire/ -- Everest Medicines
2021-03-22 15:06
3501
Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
BEIJING, March 22, 2021 /PRNewswire/ -- Nanjing Jiangbei New Area, a state-level new area in eastChina's Jiangsu Province, sent invitation to global investors to enterChina's buoyant life and health market, according to a promotion meeting held recently inShanghai. At present, the new pharmaceut...
2021-03-22 14:45
3717
Everest Medicines Announces Acceptance of New Drug Application by China NMPA for Xerava(TM) for the Treatment of Complicated Intra-abdominal Infections
SHANGHAI, March 22, 2021 /PRNewswire/ -- Everest Medicines
2021-03-22 10:40
4417
Antengene to Present Preclinical Data Demonstrating the Synergistic Effect of the Combination of XPO1 and mTORC1/2 Inhibition for the Treatment of Triple-Hit DLBCL at AACR Annual Meeting 2021
SHANGHAI and GAITHERSBURG, Md., March 22, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolog...
2021-03-22 08:00
3541
Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
HANGZHOU, China, March 22, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("INF"), a biopharmaceutical innovation and partnership company, announced today the completion of a625M CNY ($96M) Series A financing, which follows a 170M CNY ($24M) Pre-A financing completed in June 2020. The Series A ...
2021-03-22 08:00
4840
Qiming's Portfolio Company Connect Biopharma Lists on Nasdaq
SHANGHAI, March 20, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Connect Biopharma today listed on the Nasdaq with the stock code "CNTB". The issue price isUS$ 17.00/ADS. The stock opened at US$19.55/ADS and closed atUS$18.49/ADS on the first trading day, up 8.8%, with a market...
2021-03-20 09:00
16110
MGI Contributes to Africa's COVID-19 Response Efforts
SHENZHEN, China, March 18, 2021 /PRNewswire/ -- MGI
2021-03-18 22:02
2769
BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program
VANCOUVER, BC, March 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into an agreement with Bioanalytical Systems, Inc. d...
2021-03-18 20:09
5155
Biobohemia Released Paper on the Discovery of the Antigenic Essence of Cancer Cells
BOSTON, March 17, 2021 /PRNewswire/ -- Scientists announced today that they have discovered why they have not succeeded in developing a vaccine against cancer. Vaccination is a powerful tool that has helped us cope with many dangerous diseases, and it is an effective means of combatting the curre...
2021-03-17 20:00
1647
Week's Top Stories
Most Reposted
Amorepacific Showcases Innovative Technologies at CES 2026
[Picked up by 292 media titles]
2026-01-05 12:14
Novo Nordisk International Operations Commits to Veeva Vault CRM
[Picked up by 290 media titles]
2026-01-08 09:05Courtyard by Marriott Phuket, Patong Beach Resort: The Ultimate Family-Friendly Destination in 2026
[Picked up by 284 media titles]
2026-01-08 12:01
Radisson Hotel Group Revives Bangkok Icon with Opening of Radisson Hotel Chateau de Bangkok
[Picked up by 283 media titles]
2026-01-06 10:45
Panduit Announces Key Executive Appointments to Support Strategic Growth and Innovation
[Picked up by 282 media titles]
2026-01-07 10:00
